The Deal
Saturday, November 21, 
7:02 pm

Dealmaking fuels Monday market surge

  Share     E-Mail    Discussion    Print Story
Published April 7, 2008 at 1:41 PM

bull.jpgThe week started strong with deals in the drug industry, financial sector and some movement in the Microsoft Corp.-Yahoo! Inc. proposed transaction. Markets responded positively to the deal activity, increasing 84.75, or 0.67%, to 12,693.60 in Monday midday trading, and the Nasdaq inched up 13.66, or 0.58%, to 2384.64. Here's a closer look at the performance of stocks involved in deals:

Continue reading below

Also on Dealscape

  • Shares of Swiss drug giant Novartis SA [NVS] dipped on its purchase of Alcon Inc. [ACL], the eye-care business of Nestle SA. The deal calls for Novartis to buy 25% of an Alcon stake for $11 billion and the right to acquire 52% of the rest of the company for $28 billion by July 2011.
  • Meanwhile, shares of LifeCell Corp. [LIFC] shot up 16% on Kinectic Concepts Inc.'s [KCI] $1.7 billion cash offer for the maker of tissue repair products for reconstructive, urogynecologic and orthopedic surgeries. The San Antonio-based acquirer, which concentrates its business in advanced wound care and therapeutic support systems, aims to bolster its presence in operating rooms and acute-care environments with the deal.
  • Mortgage lender Washtington Mutual Inc. [WM] jumped nearly 25% as it reportedly may get a a $5 billion shot in the arm from a group led by private equity firm TPG.
  • Lastly, Microsoft Corp. [MSFT] is threatening Yahoo! Inc. [YHOO] that it will pursue a hostile takeover if they don't agree to a deal within the next three weeks, the Deal's senior writer Donna Block reports.

- Gerald Magpily



Tags

Categories



Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Avaya Inc.'s Mohamad Ali on the company's next target.

More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Managing your shareholder base

By Bradford P. Weirick and Joelle Khoury, Gibson Dunn

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

By Derek Watson, KPMG

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.


Editor's Note

Editor's letter: Nov. 16, 2009

By Robert Teitelman

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.